期刊文献+

慢性肾脏病肺动脉压变化及其相关因素分析 被引量:6

The Level of Pulmonary Aterial Systolic Pressure in CKD and its Relevant Factors
下载PDF
导出
摘要 目的:探讨慢性肾脏病(CKD)患者肺动脉压变化情况及其相关因素。方法:选取167例(CKD1期~CKD5期)非透析慢性肾脏病患者和17例健康对照者,测定并比较各组肺动脉压(PASP)和血浆脑钠肽(BNP)、血红蛋白(Hb)、甲状旁腺素(PTH)及钙磷乘积的差异,探讨CKD患者肺动脉压变化及其相关因素。结果:(1)从CKD1期起,肺动脉压随肾功能恶化逐渐升高,CKD3期开始其变化更加明显。CKD3期较CKD2期、CKD4期较CKD3期、CKD5期较CKD4期之肺动脉压差异均有统计学意义(P<0.01);17.96%(30/167)CKD患者合并肺动脉高压(PHT;PASP≥40mmHg);(2)与肺动脉压正常组相比,PHT组患者BUN、Scr、PTH、钙磷乘积和ln(BNP)均显著增高(P<0.05),而Hb却明显下降(P<0.01)。肺动脉压与ln(BNP)、Scr、BUN、PTH、钙磷乘积呈正相关(P<0.01),与Hb水平负相关(P<0.01)。ln(BNP)和Hb进入以肺动脉压为因变量的回归方程:y=20.404+3.556x1-0.103x2,其中y代表PASP(mmHg),x1为血浆ln(BNP)(pg/ml),x2为Hb(g/L)。结论:慢性肾脏病患者容易合并肺动脉高压,其严重程度及发生率与CKD严重程度相关。血浆脑钠肽水平和贫血程度与肺动脉高压形成密切相关。 Objective:To explore the level of pulmonary aterial systolic pressure in CKD patients and discover its relevant factors.Methods:167 CKD patients divided into five groups according to CKD stage and 17 healthy individuals were enrolled.Then We analysed pulmonary aterial systolic pressure (PASP)、plasm brain natriuretic peptide (BNP)、Hemoglobin(Hb)、Parathyroid hormone(PTH) and Calcium Phosphate product(Ca2+×P3-) among every group,try to explore the change of pulmonary aterial systolic pressure levels in CKD patients and discover the relevant factors.Results:(1) The level of PASP increased with CKD degression from CKD1 stage,and became much higher since CKD3 stage.Significant differences (P0.01)existed between PASP of CKD3 and CKD2 stage,CKD4 and CKD3 stage,CKD5 and CKD4 stage.17.96% (30/167)CKD patients enrolled complicated with Pulmonary hypertention(PHT;PASP≥40 mmHg);(2) Compared to patients with normal pulmonary aterial systolic pressure,the PHT group got higher BUN、Scr、PTH、Cap and ln(BNP)(P0.05),but lower Hb level (P0.01)。PASP was positively correlated with ln(BNP)、Scr、BUN、PTH、Cap(P0.01),negatively relevant to Hb(P0.01)。Ln(BNP) and Hb entered the regression equation: y=20.404+3.556 x1-0.103 x2,y meant PASP(mmHg),x1 ln(BNP)(pg/ml),x2 Hb(g/L)。Conclusion:Pulmonary hypertention declines to be developped in CKD patients as kidney disease deteriorate.Plasm brain natriuretic peptide and Hb are both closely correlated with Pulmonary hypertention.
出处 《中国中西医结合肾病杂志》 2011年第8期702-705,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 慢性肾脏病 肺动脉高压 Chronic kidney disease Pulmonary hypertention
  • 相关文献

参考文献10

  • 1Yigla M,Nakhoul F,Sabag A,et al.Pulmonary hypertension in patients with end-stage renal disease[].Chest.2003
  • 2Amin M,Fawzy A,Hamid MA,et al.Pulmonary Hypertension in Patients With Chronic Renal Failure[].Chest.2003
  • 3Abdelwhab S,Elshinnawy S.Pulmonary hypertension in chronic renal failure patients[].American Journal of Nephrology.2008
  • 4McQuillan BM,Picard MH,Leavitt M, et al.Clinical correlates and reference intervals for pulmonary artery systolic pressure among echo cardio graphically normal subjects[].Circulation.2001
  • 5Yigla M,Dabbah S,Azzam ZS,Rubin AH,Reisner SA.Background diseases in 671 patients with moderate to severe pulmonary hypertension[].The Israel Medical Association Journal.2000
  • 6Cargill RI,Lipworth BJ.Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans[].British Journal of Clinical Pharmacology.1995
  • 7Y Havlucua,S Kursatb,C Ekmekcic,P Celikd,S Sertere,O Bayturanc.Pulmonary hypertension in patients with chronic renal failure[].Respiration.2007
  • 8Berger M,Haimowitz A,Van Tosh A,et al.Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound[].Journal of the American College of Cardiology.1985
  • 9Nagaya N,Nishkimi T,Okano Y,et al.Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension[].Journal of the American College of Cardiology.1998
  • 10Nagaya N,Nishikimi T,Uematsu M,et al.Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension[].Circulation.2000

同被引文献40

  • 1兰雷,汪鹏,刁秀竹,任伟.维持性血液透析患者的临床流行病学变迁[J].中国血液净化,2012,11(5):280-283. 被引量:41
  • 2Yigla M, Nakhoul F, Sabag A, et al. Pulmonary hypertension in patients with end-stage renal disease. Chest, 20(/3, 123: 1577- 1582.
  • 3Amin M, Fawzy A, Hamid MA, et al. Pulmonary Hypertension in patients with chronic renal failure. Chest, 2003,124: 2093-2097.
  • 4Berger M, Haimowitz A, Van Tosh P, et al. Quantitative assess- ment of pulmonary hypertension in patients with tricuspid regur- gitation using continuous wave Doppler ultrasound. J Am Coll Cardiol, 1985,6 : 359-365.
  • 5Meouillan BM, Picard MH, Leavitt M, et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure a- mong eehoeardiographieally normal subjeets. Circulation, 2001, 104 : 2797-2802.
  • 6Havlucu Y,Kursat S, Ekmekci C, et al. Pulmonary hypertension in patients with chronic renal failure. Respiration,2007,74.503- 510.
  • 7Leuchte HH, Holzapfel M, Baumgartner RA, et al. Clinical signif- icance of brain natriuretic peptide in primary pulmonary hyper- tension. J Am Coil Cardiol, 2004,43 : 764-770.
  • 8Cargill RI, Lipworth BJ. Acute effects of ANP and BNP on hy- poxie pulmonary vasoconstriction in humans. Br J Clin Pharma- col, 1995,40 : 585-590.
  • 9Bolignano D, Rastelli S, Agarwal R, et al. Pulmonary hypertension in CKD. Am J Kidney Dis,2013,61 (4) :612 -622.
  • 10Yigla M, Fmchter O, Aharonson D, et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney international. May,2009,75 (9) :969 - 975.

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部